Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

rizatriptan benzoate

RIZATRIPTAN BENZOATE

rizatriptan benzoate (RIZATRIPTAN BENZOATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 20
Pipeline programs 0
News articles 0
Drug details — rizatriptan benzoate
US status
approved
Class
—
Route
ORAL
Patents
20
Programs
0
Data quality
0.89
← All drugs Manufacturer profile Related patents Drug news hub Event calendar

Quick answer

rizatriptan benzoate (RIZATRIPTAN BENZOATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN rizatriptan benzoate
Brand RIZATRIPTAN BENZOATE
Mechanism Serotonin 1d (5-HT1d) receptor agonist
Target 5-hydroxytryptamine receptor 1B
Route ORAL
Formulation TABLET, ORALLY DISINTEGRATING
Originator Teva Pharma GmbH

Mechanism of action

Serotonin 1d (5-HT1d) receptor agonist

Primary target: 5-hydroxytryptamine receptor 1B

Approval history

Authority Status Date
FDA approved —

Related & competitor drugs

Browse all drugs
  1. almotriptan malate Serotonin 1f (5-HT1f) receptor agonist
  2. eletriptan hydrobromide Serotonin 1b (5-HT1b) receptor agonist
  3. frovatriptan succinate Serotonin 1b (5-HT1b) receptor agonist
  4. sumatriptan Serotonin 1b (5-HT1b) receptor agonist
  5. sumatriptan succinate Serotonin 1d (5-HT1d) receptor agonist
  6. zolmitriptan Serotonin 1d (5-HT1d) receptor agonist

Related patents

Browse patents Teva Pharma GmbH patent hub

  1. US 12370196

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12128052

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11865117

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11826370

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11806354

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11801250

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11759522

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11738085

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11712441

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11628173

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11617791

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11617756

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11617755

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11607456

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11602563

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11571428

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11510927

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11504429

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11471464

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11471465

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is rizatriptan benzoate?

rizatriptan benzoate (RIZATRIPTAN BENZOATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for rizatriptan benzoate?

RIZATRIPTAN BENZOATE is a marketed brand name for rizatriptan benzoate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of rizatriptan benzoate?

rizatriptan benzoate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.